Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Current Leases (2016 - 2025)

Historic Current Leases for Enanta Pharmaceuticals (ENTA) over the last 9 years, with Q3 2025 value amounting to $3.1 million.

  • Enanta Pharmaceuticals' Current Leases rose 10643.04% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 10643.04%. This contributed to the annual value of $3.1 million for FY2025, which is 10643.04% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Current Leases of $3.1 million as of Q3 2025, which was up 10643.04% from $2.4 million recorded in Q2 2025.
  • Enanta Pharmaceuticals' Current Leases' 5-year high stood at $5.4 million during Q2 2023, with a 5-year trough of $1.0 million in Q4 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' median Current Leases value was $3.5 million (recorded in 2021), while the average stood at $3.5 million.
  • Per our database at Business Quant, Enanta Pharmaceuticals' Current Leases soared by 10654.1% in 2023 and then tumbled by 7974.22% in 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Current Leases (Quarter) stood at $3.5 million in 2021, then rose by 0.49% to $3.5 million in 2022, then surged by 42.46% to $5.0 million in 2023, then crashed by 79.74% to $1.0 million in 2024, then skyrocketed by 212.72% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $2.4 million for Q2 2025, and $2.2 million during Q1 2025.